Patient Association: Myeloma Patients Europe (MPE) (European Union): Difference between revisions
From Beacon
m (Update categories.) |
m (Update categories.) |
||
| Line 18: | Line 18: | ||
<span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | <span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | ||
<span style="display:none">hasCancerType::C00-C97: All cancer types</span> | <span style="display:none">hasCancerType::C00-C97: All cancer types</span> | ||
<span style="display:none">Lymphatic</span> | |||
<span style="display:none">Lymphoid</span> | |||
<span style="display:none">Lymphoma</span> | |||
<span style="display:none">Hematologic</span> | |||
<span style="display:none">Hematopoietic</span> | |||
<span style="display:none">Myeloma</span> | |||
<span style="display:none">Plasma cell</span> | |||
Latest revision as of 12:07, 14 December 2025
Go back to European Union page
Primary purpose: To educate, inform, and support member groups while advocating for the best research, treatment, and care across Europe.
Cancer areas of interest: C81-C96: Cancers of the blood and immune system.
Access to information: Click here to access.
